3rd Edition Novel Formulation Strategies is organized by Select Biosciences India Pvt. Ltd. and will be held from May 23 - 24, 2019 at Sheraton Hyderabad Hotel, Hyderabad, Telangana, India.
"Novel Formulation Strategies" is a unique, Pharma Industry focused, event designed to discuss novel strategies for pharmaceutical product development. India is the largest manufacturer of generic medicines globally and therefore drug formulation strategies need to be updated and discussed in order to successfully develop novel formulations. This event will include discussions by Pharma Industry Experts covering issues like Solubility & Oral Bioavailability Enhancement, Modified Release Formulations, Difficult to Formulate FDC, Water Insoluble drugs and 505(b)2 – Innovations for US market. The organizers envisage to bring more and more overseas and industry scientists as speakers.
Academic Innovation Session: In this event a special session has been designated towards Academic Innovations. A large number of Pharmaceutical Scientists in Academic Institutions have been working on formulation development. In this session we aim to present selected Academic Formulation related Innovations which might have importance in industry but could otherwise go unnoticed by industry scientists. This session will be open to Regular PhD Research Scholars only. Each presentation will be for 5-10 minutes duration only and will be adjudged by the industry scientists. The presentation providing best innovation and/or solution with direct application in pharmaceutical industry will be awarded Rs 5100/-during the closing ceremony of the conference. In addition the 2nd and 3rd position presentations will be awarded Rs 3100/- and Rs 2100/- respectively. Faculty (Registered Indian Delegate) presenting the innovation will not be eligible for the award but will be allowed to present.
The last date for submission of abstract for presentation in this session is up to February 15, 2019. The selected abstracts will be intimated latest by February
For detailed information about speakers and presentations, please contact Ms Pooja Sharma, Email: email@example.com, or Call +91 7696325050 or WhatsApp: 9041725050.
• Bioequivalence and Biowaiver Strategies
○ BCS 1-3 Oral Solid Dosage Forms
○ Oral Extended/Modified Release Formulations
• Drug Delivery Systems
○ Lipid based Systems
○ Permeation Enhanced Topical Preparations
○ Spray Systems for Nasal Preparations
• Formulation Development Approaches
○ Difficult to Formulate FDC
○ QbD Approaches
○ Taste Masking of Pediatric PFOS Dosage Forms
○ Temperature/Moisture Sensitive Drugs
○ Water Insoluble Drugs for IV Injections
• Innovations for US/Europe Markets
○ 505(b)(2), ANDA
• Solubility and Oral Bioavailability Enhancement
• Stability Issues with Formulations and Complex Generics
Call for Papers:
If you would like to be considered for an oral presentation at this meeting, Submit an abstract for review now!
Oral Submission Deadline: 30th Nov 2018
Exhibition & Registration:
Cell: 7696125050, 7696525050
Overseas Delegate $ 600
Overseas Pre-Doctoral Delegate $ 200
Overseas Business Delegate $ 800
|Contact No. :||+91 7696125050
April 15, 2019
|Registration Type||End Date||Price|
|India Business Delegate Fee||22 May,2019||INR 25000.00|
|Indian Industry Delegate Fee||22 May,2019||INR 18000.00|
|Pre-Doctoral Oral Presenter Fee||22 May,2019||INR 5000.00|
|Oral Presenter Fee||22 May,2019||INR 8000.00|